Literature DB >> 15779485

Pulmonary metastasectomy for hepatocellular carcinoma.

Yo-Ju Chen1, Han-Shui Hsu, Chih-Cheng Hsieh, Yu-Chung Wu, Liang-Shun Wang, Wen-Hu Hsu, Min-Hsiung Huang, Biing-Shiun Huang.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is seldom resectable due to advanced status. Even though hepatectomy is feasible, a large proportional of patients may still develops extrahepatic recurrence. Pulmonary metastasis is the most common site of extrahepatic spread. Few articles have discussed the benefit of resection for lung metastasis after curative hepatectomy. We evaluated the general information and the result of lung resection for patients having lung metastasis after curative resection of HCC.
METHODS: Six patients who underwent pulmonary metastasectomy for HCC at Taipei Veterans General Hospital between August 1995 and May 2004 were enrolled in the study. All of them had received the hepatectomy for primary HCC. The demographic information of patients, the site and number of extrahepatic recurrence, the method of surgical intervention and the outcome after surgery were retrospectively reviewed.
RESULTS: There were 4 men and 2 women with the mean age of 47.3 years. All of them were HBV carriers. Five patients had multiple pulmonary metastases removed by wedge resection. Two patients had bilateral lung metastases upon diagnosis of extrahepatic recurrence. The mean duration of follow-up after hepatic resection was 75.0 +/- 25.1 months (32 to 104 months). The mean survival after pulmonary resection was 47.2 +/- 34.3months (1 to 94 months). Four patients are still alive and free of the disease. One patient is alive but with the disease. One patient who refused further aggressive treatment after resection of lung metastasis died of the disease 40 months after lung resection, 77 months after hepatic resection.
CONCLUSIONS: Lung resection for the pulmonary metastasis of HCC can result in a favorable long-term survival when there is no other intrahepatic or extraphepatic recurrence of HCC. For patients with multiple lung metastases in different lobes or different lungs, aggressive surgical resection is recommended if complete resection can be achieved.

Entities:  

Mesh:

Year:  2004        PMID: 15779485

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  6 in total

1.  Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?

Authors:  Won-Gun Yun; Wooil Kwon; Youngmin Han; Hee Ju Sohn; Hyeong Seok Kim; Mirang Lee; Hongbeom Kim; Alexander S Thomas; Michael D Kluger; Jin-Young Jang
Journal:  Cancers (Basel)       Date:  2022-04-20       Impact factor: 6.575

2.  Pulmonary resection for metastases from hepatocellular carcinoma.

Authors:  Fengshi Chen; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

3.  Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors.

Authors:  Jong-Bum Kwon; Khun Park; Young-Du Kim; Jong-Hee Seo; Seok-Whan Moon; Deog-Gon Cho; Yong-Whan Kim; Dong-Goo Kim; Seung-Kew Yoon; Hyeon-Woo Lim
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

4.  Clinical Factors Predicting Better Survival Outcome for Pulmonary Metastasectomy of Hepatocellular Carcinoma.

Authors:  Tse-Ming Kuo; Kai-Ming Chang; Tsun-I Cheng; Kuo-Jang Kao
Journal:  Liver Cancer       Date:  2017-08-29       Impact factor: 11.740

5.  Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma.

Authors:  Shuenn-Wen Kuo; Yih-Leong Chang; Pei-Ming Huang; Hsao-Hsun Hsu; Jin-Shin Chen; Jang-Ming Lee; Po-Huang Lee; Yung-Chie Lee
Journal:  Ann Surg Oncol       Date:  2006-12-06       Impact factor: 5.344

6.  Efficacy of surgical resection for pulmonary metastases from hepatocellular carcinoma.

Authors:  Yan-Ming Zhou; Xiao-Feng Zhang; Feng Yu; Xiao-Bin Liu; Lu-Peng Wu; Bin Li; Jia-Mei Yang
Journal:  Med Sci Monit       Date:  2014-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.